Академический Документы
Профессиональный Документы
Культура Документы
Brand Name Atripla Generic Name Manufacturer Name Approval Date 12-July-06 Time to Approval 2.5 months efavirenz, emtricitabine and Bristol-Myers Squibb and Gilead tenofovir disoproxil Sciences fumarate emtricitabine, rilpivirine, and Gilead Sciences tenofovir disoproxil fumarate
Complera
10-August-11
6 months
zalcitabine, dideoxycytidine, Hoffmann-La Roche ddC (no longer marketed) zidovudine, azidothymidine, GlaxoSmithKline AZT, ZDV abacavir, zidovudine, and lamivudine tenofovir disoproxil fumarate and emtricitabine enteric coated didanosine, ddI EC GlaxoSmithKline Gilead Sciences, Inc. Bristol Myers-Squibb
didanosine, dideoxyinosine, Bristol Myers-Squibb ddI tenofovir disoproxil fumarate, TDF stavudine, d4T abacavir sulfate, ABC Gilead Bristol Myers-Squibb GlaxoSmithKline
Generic Name rilpivirine etravirine delavirdine, DLV efavirenz, EFV nevirapine, NVP
Manufacturer Name Tibotec Therapeutics Tibotec Therapeutics Pfizer Bristol Myers-Squibb Boehringer Ingelheim Boehringer Ingelheim
Time to Approval 10 months 6 months 8.7 months 3.2 months 3.9 months 9.9 months
Fusion Inhibitors
Brand Name Fuzeon Generic Name enfuvirtide, T-20 Manufacturer Name Hoffmann-La Roche & Trimeris Approval Date 13-Mar-03 Time to Approval 6 months